Savill Corrine 4
4 · Cullinan Oncology, Inc. · Filed Feb 21, 2023
Insider Transaction Report
Form 4
Savill Corrine
Chief Business Officer
Transactions
- Award
Common Stock
2023-02-17+20,500→ 170,115 total - Award
Stock Option (Right to Buy)
2023-02-17+41,000→ 41,000 totalExercise: $11.34Exp: 2033-02-16→ Common Stock (41,000 underlying)
Footnotes (2)
- [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
- [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.